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We recently described a transgenic mouse model of hearing loss 
induced by over-expression of the mitochondrial ribosomal RNA 
(rRNA) methyltransferase, TFB1M (Tg-TFB1M).  These mice 
recapitulate maternally inherited deafness caused by the human 
A1555G mtDNA mutation, which results in increased methylation 
of the 12S rRNA in mitochondrial ribosomes and tissue-specific 
susceptibility to apoptosis.  The present study aims to identify the 
specific cellular and tissue based pathologies underlying this form 
of deafness. 
Hair Cell Loss Does not Correspond to Hearing Loss in 
TFB1M mice 
Stria vascularis dysfunction occurs in TFB1M mice 
Stria vascularis in the TFB1M mice is not atrophied. 
Patterns of altered gene expression revealed by 
microarray analysis of the stria vascularis of 
TFB1M mice suggest several stress pathways that 
may mediate the hearing loss.    Hybridization microarrays 
(Affymetrix) were performed on RNA collected from the stria vasculari of hearing 
and non-hearing (TFB1M) mice.  The results were analyzed with the Ingenuity 
Pathway Analysis software (Qiagen) to identify groups of regulated genes 
associated with known signaling pathways or known to be regulated by specific 
transcription factors or drugs.  The top ten signaling pathways implicated in the 
analysis include an immune response pathway (in yellow below.)  What’s more, one 
of the top implicated upstream regulators of genes with altered expression in the 
microarray is predinsone.  Together these results support the idea that the stria is 
under inflammatory stress.   
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TFB1M mice do not show significant loss of Myo7A labeled hair 
cells (left panels). The sporadic hair cell loss found in these animals 
does not correspond to the extent of ABR threshold increase. When 
studied in isolation, patch clamped outer hair cells show robust 
nonlinear capacitance and electromotility (right panel).  The shift of 
NLC in TFB1 mice indicates some change of OHC function may 
have occurred. We intend to explore with OAE.  
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As reported earlier (see Raimundo et al 2012) TFB1M mice 
show progressive hearing loss at the age of 9-13 month. The 
across frequency threshold elevation measured by ABR (left 
panel) is accompanied with the loss of endocochlear potential 
(right panel). 
Thickness of the Stria Vascularis
W
T B1
0
5
10
15
20
25
n=7n=9
T
h
ic
k
n
e
s
s
 u
m
WT B1 
The width of the stria was measured at the widest point on 
sections through the middle turn of the cochleae show no 
evidence of atrophy (upper panels). However, 
degenerative changes in the stria vascularis are evident 
under EM (lower panels). 
Several recent studies have shown that mitochondrial 
reactive oxygen species activate cellular stress pathways, 
including DNA damage response and inflammatory 
pathways.  The evidence provided here suggests that ROS 
induced deafness due to TFB1M over-expression may 
result in inflammatory changes in the stria vascularis that 
lead to hearing loss.  The sparing of hair cells in our 
model may point to possible therapeutic options for 
patients affected by mitochondrially induced hearing loss. 
A Model of Mitochondrially 
Induced Deafness:  
Overexpression of TFB1M or the 
presence of the A1555G mutation 
leads to the hypermethylation of 
the mitochondrial 12S ribosomal 
subunit. The result of 
hypermethylation is increased 
oxidative stress and hearing loss 
through an AMPK and E2F1 
dependent pathway. 
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